VEOZAH
VEOZAH
Approved
DIN Number
02553600
Drug Class
Human
Market Date
Mar 11, 2025
Company
HC
astellas pharma canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02553600
AIG Number0166344001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
G02CX06 FEZOLINETANT
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:92.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
FEZOLINETANTActive
Strength: 45 MG
Monograph: FEZOLINETANT